Neil J Stone

  • 23771 Citations
1968 …2019
If you made any changes in Pure, your changes will be visible here soon.

Research Output 1968 2019

2019
Secondary Prevention
Cholesterol
Guidelines
Primary Prevention
Cholesterol
Guidelines
2 Citations (Scopus)

Applicability and Cost Implications for Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors Based on the ODYSSEY Outcomes Trial

Virani, S. S., Akeroyd, J. M., Nambi, V., Michos, E. D., Morris, P. B., Nasir, K., Smith, S. C., Stone, N. J., Petersen, L. A. & Ballantyne, C. M., Jan 15 2019, In : Circulation. 139, 3, p. 410-412 3 p.

Research output: Contribution to journalLetter

Cholesterol
Clinical Trials
Costs and Cost Analysis
Proprotein Convertase 9
1 Citation (Scopus)

Clinician's Guide to the Updated ABCs of Cardiovascular Disease Prevention: A Review Part 1

Arps, K., Pallazola, V. A., Cardoso, R., Meyer, J., Jones, R., Latina, J., Gluckman, T. J., Stone, N. J., Blumenthal, R. S. & McEvoy, J. W., Jan 1 2019, In : American Journal of Medicine.

Research output: Contribution to journalReview article

Cardiovascular Diseases
Guidelines
Preventive Medicine
Primary Prevention
Secondary Prevention
1 Citation (Scopus)

Clinician's Guide to the Updated ABCs of Cardiovascular Disease Prevention: A Review Part 2

Arps, K., Pallazola, V. A., Cardoso, R., Meyer, J., Jones, R., Latina, J., Gluckman, T. J., Stone, N. J., Blumenthal, R. S. & McEvoy, J. W., Jan 1 2019, In : American Journal of Medicine.

Research output: Contribution to journalReview article

Cardiovascular Diseases
Practice Guidelines
Tobacco Use Cessation
Preventive Medicine
Risk Reduction Behavior

Differences in statin utilization and lipid lowering by race, ethnicity, and HIV status in a real-world cohort of persons with human immunodeficiency virus and uninfected persons

Riestenberg, R. A., Furman, A., Cowen, A., Pawlowksi, A., Schneider, D., Lewis, A. A., Kelly, S., Taiwo, B. O., Achenbach, C. J., Palella Jr, F. J., Stone, N. J., Lloyd-Jones, D. M. & Feinstein, M. J., Mar 1 2019, In : American heart journal. 209, p. 79-87 9 p.

Research output: Contribution to journalArticle

Hydroxymethylglutaryl-CoA Reductase Inhibitors
HIV
Lipids
HIV Infections
Cardiovascular Diseases

Four Cases of Cholesterol Management Informed by the 2018 American Heart Association/American College of Cardiology Multisociety Guideline on the Management of Blood Cholesterol

Chuzi, S., Pfenniger, A., Lloyd-Jones, D. M., Blumenthal, R. S., Smith, S. C., Virani, S. S., Grundy, S. M. & Stone, N. J., Jan 1 2019, In : JAMA Cardiology.

Research output: Contribution to journalArticle

Case Management
Cholesterol
Guidelines
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hyperlipoproteinemia Type II

Treatment Gap in Primary Prevention Patients Presenting With Acute Coronary Syndrome

Bavishi, A., Howard, T., Kim, J. P., Hiramoto, B., Pierce, J. B., Mendapara, P., Alhalel, J., Wu, H. W., Srdanovich, N. & Stone, N. J., Feb 1 2019, In : American Journal of Cardiology. 123, 3, p. 368-374 7 p.

Research output: Contribution to journalArticle

Primary Prevention
Acute Coronary Syndrome
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Blood Pressure
American Heart Association
2018
6 Citations (Scopus)

A Comparative Analysis of Current Lipid Treatment Guidelines: Nothing Stands Still

Tibrewala, A., Jivan, A., Oetgen, W. J. & Stone, N. J., Feb 20 2018, In : Journal of the American College of Cardiology. 71, 7, p. 794-799 6 p.

Research output: Contribution to journalReview article

Hydroxymethylglutaryl-CoA Reductase Inhibitors
Guidelines
Lipids
Therapeutics
United States Department of Veterans Affairs

A New HOPE? Lessons from Heart Outcomes Prevention Evaluation-3

Howard, T. M., Bavishi, A. A. & Stone, N. J., Feb 1 2018, In : American Journal of Medicine. 131, 2, p. 134-140 7 p.

Research output: Contribution to journalReview article

Hydroxymethylglutaryl-CoA Reductase Inhibitors
Cardiovascular Diseases
Randomized Controlled Trials
Population
Group Psychotherapy

Measuring low-density lipoprotein cholesterol when is more accurate better?

Stone, N. J., Aug 1 2018, In : JAMA Cardiology. 3, 8, p. 754-755 2 p.

Research output: Contribution to journalComment/debate

LDL Cholesterol
7 Citations (Scopus)

Statins for Primary Prevention in Older Adults—Moving Toward Evidence-Based Decision-Making

Singh, S., Zieman, S., Go, A. S., Fortmann, S. P., Wenger, N. K., Fleg, J. L., Radziszewska, B., Stone, N. J., Zoungas, S. & Gurwitz, J. H., Nov 1 2018, In : Journal of the American Geriatrics Society. 66, 11, p. 2188-2196 9 p.

Research output: Contribution to journalReview article

Hydroxymethylglutaryl-CoA Reductase Inhibitors
Primary Prevention
Decision Making
Cardiovascular Diseases
Randomized Controlled Trials

Sudden Creatine Kinase Elevation When an Athlete Starts Boxing: Looking Deeper Prior to Knocking the Statin Out

Bavishi, A., Howard, T., Rosen, A. & Stone, N. J., Aug 1 2018, In : American Journal of Medicine. 131, 8, p. e333-e334

Research output: Contribution to journalArticle

Boxing
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Creatine Kinase
Athletes
2017
150 Citations (Scopus)

Dietary fats and cardiovascular disease: A presidential advisory from the American Heart Association

Sacks, F. M., Lichtenstein, A. H., Wu, J. H. Y., Appel, L. J., Creager, M. A., Kris-Etherton, P. M., Miller, M., Rimm, E. B., Rudel, L. L., Robinson, J. G., Stone, N. J. & Van Horn, L., Jul 18 2017, In : Circulation. 136, 3, p. e1-e23

Research output: Contribution to journalReview article

Dietary Fats
Cardiovascular Diseases
Fats
Unsaturated Fats
Cause of Death
1 Citation (Scopus)

Factors affecting the cost of airplanes and use of proprotein convertase subtilisin/kexin type 9 inhibitors

Stone, N. J., Jun 1 2017, In : JAMA Cardiology. 2, 6, p. 596-597 2 p.

Research output: Contribution to journalEditorial

Aircraft
Costs and Cost Analysis
Proprotein Convertase 9

Low-density lipoprotein measurement discordance: When 2 wrongs lead to the right answer-elevated lipoprotein (a)

Intwala, S., Stone, N. J. & Balady, G. J., Jun 1 2017, In : JAMA Cardiology. 2, 6, p. 697-698 2 p.

Research output: Contribution to journalShort survey

Lipoprotein(a)
LDL Lipoproteins
3 Citations (Scopus)

Potential for Net Benefit Should Guide Preventive Therapy

Stone, N. J. & Robinson, J. G., Feb 14 2017, In : Circulation. 135, 7, p. 630-632 3 p.

Research output: Contribution to journalShort survey

LDL Cholesterol
Guidelines
Therapeutics
3 Citations (Scopus)
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Therapeutics
Mortality
Transcatheter Aortic Valve Replacement
Survival
4 Citations (Scopus)

Statin Prescribing in the Elderly: Special Considerations

Leya, M. & Stone, N. J., Nov 1 2017, In : Current Atherosclerosis Reports. 19, 11, 47.

Research output: Contribution to journalReview article

Hydroxymethylglutaryl-CoA Reductase Inhibitors
Primary Prevention
Randomized Controlled Trials
Therapeutics
Aptitude
1 Citation (Scopus)

Statins in Secondary Prevention: Intensity Matters

Stone, N. J., Jun 6 2017, In : Journal of the American College of Cardiology. 69, 22, p. 2707-2709 3 p.

Research output: Contribution to journalEditorial

Hydroxymethylglutaryl-CoA Reductase Inhibitors
Secondary Prevention
Coronary Disease
Myocardial Infarction

Use of statins in adults older than 75 years

Stone, N. J. & Blum, C. B., Mar 14 2017, In : JAMA - Journal of the American Medical Association. 317, 10, 1 p.

Research output: Contribution to journalLetter

Hydroxymethylglutaryl-CoA Reductase Inhibitors
Primary Prevention
Cardiovascular Diseases
2016
4 Citations (Scopus)

Advances in lipid testing: A practical step forward

Stone, N. J., Jul 1 2016, In : Clinical Chemistry. 62, 7, p. 905-906 2 p.

Research output: Contribution to journalEditorial

Lipids

Author's Reply

Yadlapati, A., Taylor, A. P., Stone, N. J., Bonow, R. O. & Puthumana, J. J., May 1 2016, In : Clinical Cardiology. 39, 5, 1 p.

Research output: Contribution to journalLetter

31 Citations (Scopus)

Fasting or Nonfasting Lipid Measurements It Depends on the Question

Driver, S. L., Martin, S. S., Gluckman, T. J., Clary, J. M., Blumenthal, R. S. & Stone, N. J., Mar 15 2016, In : Journal of the American College of Cardiology. 67, 10, p. 1227-1234 8 p.

Research output: Contribution to journalReview article

Fasting
Lipids
Cardiovascular Diseases
Hypertriglyceridemia
Primary Prevention

Getting What the Guidelines Stated Matters

Stone, N. J., Lloyd-Jones, D. M. & Smith, S., Jan 5 2016, In : Journal of the American College of Cardiology. 67, 1, p. 119-120 2 p.

Research output: Contribution to journalLetter

Azetidines
Heptanoic Acids
Pyrroles
Atherosclerotic Plaques
Percutaneous Coronary Intervention

Looking beyond Statins: Will the Dollars Make Sense?

Stone, N. J., Dec 13 2016, In : Circulation. 134, 24, p. 1944-1947 4 p.

Research output: Contribution to journalReview article

Hydroxymethylglutaryl-CoA Reductase Inhibitors
10 Citations (Scopus)

Metabolic Syndrome: An Evolving Clinical Construct

Vassallo, P., Driver, S. L. & Stone, N. J., Sep 1 2016, In : Progress in Cardiovascular Diseases. 59, 2, p. 172-177 6 p.

Research output: Contribution to journalReview article

Life Style
Cardiovascular Diseases
Technology
Waist Circumference
Atrial Fibrillation
1 Citation (Scopus)

MY APPROACH to cardiovascular risk assessment to reduce atherosclerotic risk

Stone, N. J., Jan 1 2016, In : Trends in Cardiovascular Medicine. 26, 1, p. 92-93 2 p.

Research output: Contribution to journalComment/debate

Preventive Health Services
Medication Therapy Management
Arteriosclerosis
Risk Reduction Behavior
Disease Management
2 Citations (Scopus)

New Eyes on Lipids and Lipoproteins

Stone, N. J. & Blum, C. B., Sep 1 2016, In : Progress in Cardiovascular Diseases. 59, 2, p. 95-96 2 p.

Research output: Contribution to journalEditorial

Lipoproteins
Lipids

New strategies to treat high cholesterol

Blum, C. B. & Stone, N. J., Mar 15 2016, In : JAMA - Journal of the American Medical Association. 315, 11, 1 p.

Research output: Contribution to journalLetter

Proprotein Convertases
Hypolipidemic Agents
Hyperlipidemias
LDL Cholesterol
Cholesterol
14 Citations (Scopus)

Nonfasting sample for the determination of routine lipid profile: Is it an idea whose time has come?

Rifai, N., Young, I. S., Nordestgaard, B. G., Wierzbicki, A. S., Vesper, H., Mora, S., Stone, N. J., Genest, J. & Miller, G., Mar 1 2016, In : Clinical Chemistry. 62, 3, p. 428-435 8 p.

Research output: Contribution to journalComment/debate

Lipids
8 Citations (Scopus)

Patients and physicians beliefs and practices regarding adherence to cardiovascular medication

Hines, R. & Stone, N. J., Jul 1 2016, In : JAMA Cardiology. 1, 4, p. 470-473 4 p.

Research output: Contribution to journalArticle

Physicians
Medication Adherence
Cardiology
Health Care Costs
Primary Health Care
9 Citations (Scopus)

Refining Statin Prescribing in Lower-Risk Individuals: Informing Risk/Benefit Decisions

Pender, A., Lloyd-Jones, D. M., Stone, N. J. & Greenland, P., Oct 11 2016, In : Journal of the American College of Cardiology. 68, 15, p. 1690-1697 8 p.

Research output: Contribution to journalReview article

Hydroxymethylglutaryl-CoA Reductase Inhibitors
Guidelines
Veterans
Decision Making
Cardiovascular Diseases

Reply: Lipid Measurements: Fasting or Nonfasting, Women or Men

Driver, S., Martin, S. S., Gluckman, T. J., Clary, J. M., Blumenthal, R. S. & Stone, N. J., Oct 11 2016, In : Journal of the American College of Cardiology. 68, 15, p. 1710-1711 2 p.

Research output: Contribution to journalLetter

Fasting
Lipids
14 Citations (Scopus)

Shared Decision-Making and Patient Empowerment in Preventive Cardiology

Kambhampati, S., Ashvetiya, T., Stone, N. J., Blumenthal, R. S. & Martin, S. S., May 1 2016, In : Current Cardiology Reports. 18, 5, 49.

Research output: Contribution to journalReview article

Patient Participation
Cardiology
Decision Making
Health
Medication Adherence
6 Citations (Scopus)

Statin therapy across the lifespan: Evidence in major age groups

Stone, N. J., Turin, A., Spitz, J. A., Valle, C. W. & Kazmi, S., Mar 3 2016, In : Expert Review of Cardiovascular Therapy. 14, 3, p. 341-366 26 p.

Research output: Contribution to journalReview article

Hydroxymethylglutaryl-CoA Reductase Inhibitors
Age Groups
Therapeutics
Randomized Controlled Trials
Primary Prevention
9 Citations (Scopus)

Statin Use and Aneurysm Risk in Patients with Bicuspid Aortic Valve Disease

Taylor, A. P., Yadlapati, A., Andrei, A-C., Li, Z., Clennon, C., McCarthy, P. M., Thomas, J. D., Malaisrie, S. C., Stone, N. J., Bonow, R. O., Fedak, P. W. M. & Puthumana, J. J., Jan 1 2016, In : Clinical Cardiology. 39, 1, p. 41-47 7 p.

Research output: Contribution to journalArticle

Hydroxymethylglutaryl-CoA Reductase Inhibitors
Aortic Diseases
Aneurysm
Dilatation
Aortic Valve Insufficiency
3 Citations (Scopus)

The ABCDs of lifestyle counseling

Lehr, A. L., Driver, S. L. & Stone, N. J., Aug 1 2016, In : JAMA Cardiology. 1, 5, p. 505-506 2 p.

Research output: Contribution to journalShort survey

Life Style
Counseling
8 Citations (Scopus)

The ASCVD Risk Estimator App: From Concept to the Current State

Gluckman, T. J., Kovacs, R. J., Stone, N. J., Damalas, D., Mullen, J. B. & Oetgen, W. J., Jan 26 2016, In : Journal of the American College of Cardiology. 67, 3, p. 350-352 3 p.

Research output: Contribution to journalLetter

Point-of-Care Systems
Mobile Applications
Decision Support Techniques
Atherosclerosis
Cholesterol
2 Citations (Scopus)
Natural History
Stroke
Myocardial Infarction
Population

Treatment of blood cholesterol to reduce risk for atherosclerotic cardiovascular disease

Lloyd-Jones, D. M., Goff, D. C. & Stone, N. J., Jan 19 2016, In : Annals of Internal Medicine. 164, 2, p. 135-136 2 p.

Research output: Contribution to journalLetter

Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hypercholesterolemia
Atherosclerosis
Cardiovascular Diseases
Cholesterol
4 Citations (Scopus)

What to say and how to say it: Effective communication for cardiovascular disease prevention

Navar, A. M., Stone, N. J. & Martin, S. S., Sep 1 2016, In : Current opinion in cardiology. 31, 5, p. 537-544 8 p.

Research output: Contribution to journalReview article

Cardiovascular Diseases
Communication
Guidelines
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Patient Preference
2015
28 Citations (Scopus)

ACC 2015 Core Cardiovascular Training Statement (COCATS 4) (Revision of COCATS 3): A Report of the ACC Competency Management Committee

Introduction/Steering Committee, May 5 2015, In : Journal of the American College of Cardiology. 65, 17, p. 1721-1723 3 p.

Research output: Contribution to journalArticle

47 Citations (Scopus)
Hydroxymethylglutaryl-CoA Reductase Inhibitors
HIV
Therapeutics
Cardiovascular Diseases
Safety
1 Citation (Scopus)

Cholesterol guidelines do not endorse "one size fits all": The strategy begins with a discussion

Stone, N. J., Apr 28 2015, In : Journal of the American College of Cardiology. 65, 16, p. 1640-1643 4 p., 21040.

Research output: Contribution to journalEditorial

Hydroxymethylglutaryl-CoA Reductase Inhibitors
Cardiovascular Diseases
Cholesterol
Guidelines
77 Citations (Scopus)

Clinician-patient risk discussion for atherosclerotic cardiovascular disease prevention: Importance to implementation of the 2013 ACC/AHA guidelines

Martin, S. S., Sperling, L. S., Blaha, M. J., Wilson, P. W. F., Gluckman, T. J., Blumenthal, R. S. & Stone, N. J., Jan 1 2015, In : Journal of the American College of Cardiology. 65, 13, p. 1361-1368 8 p.

Research output: Contribution to journalReview article

Cardiovascular Diseases
Guidelines
Decision Making
Patient Participation
Hydroxymethylglutaryl-CoA Reductase Inhibitors
5 Citations (Scopus)

COCATS 4 task force 2: Training in preventive cardiovascular medicine

Smith, S. C., Bittner, V., Gaziano, J. M., Giacomini, J. C., Pack, Q. R., Polk, D. M., Stone, N. J. & Wang, S., Jan 1 2015, In : Journal of the American College of Cardiology. 65, 17, p. 1754-1762 9 p.

Research output: Contribution to journalArticle

10 Citations (Scopus)
Hyperlipoproteinemia Type II
Guidelines
Cholesterol
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Lipoprotein(a)